Vaccine supply and introduction to tasks
To support the smooth implementation of vaccination programs, a stable supply of national preventive vaccination vaccines (18 infectious diseases including BCG, hepatitis B, etc.) and temporary vaccination vaccines (COVID-19, mpox) is being ensured for infection disease prevention and control.
National preventive vaccination supply method
A national program of preventive vaccination is being conducted for the prevention and control of a total of 18 infectious diseases, including tuberculosis and hepatitis B, targeting children under 13, pregnant women, and seniors over 65. Vaccines are supplied through four methods for 24 vaccine items requiring national preventive vaccinations.
Government Aggregate Purchase - Advance Physical Supply
- (Definition) After the government collectively purchases and secures the annual amount of vaccines, they are distributed to vaccination institutions (public health centers, entrusted medical institutions), and redistributed based on the vaccination situation.
- (Target Vaccines) Influenza, PPSV, typhoid fever, hantavirus, intradermal BCG, vaccines for temporary vaccination [COVID-19, mpox (monkeypox)]
Government Aggregate Purchase - Post-Physical Supply
- (Definition) For vaccines designated for individuals targeted by the national preventive vaccination program, the government supplies physical vaccines that have been collectively purchased and secured to vaccination institutions (entrusted medical institutions).
- (Target Vaccine) PCV 13-valent and 15-valent
Government Aggregate Purchase - Post-Cost Deduction
- (Definition) For vaccines designated for individuals targeted by the national preventive vaccination program, costs are reimbursed through the contracted suppliers that delivered the vaccines to the respective vaccination institutions (entrusted medical institutions).
- (Target Vaccines) HPV 4-valent
Private individual purchase
- (Definition) Vaccination institutions (entrusted medical institutions) individually purchase vaccines for use in the national preventive vaccination program, and reimbursement for vaccine purchase costs is provided for cases in which vaccines are administered to individuals targeted by the National Preventive Vaccination Program.
- (Target Vaccines) Hepatitis B, DTaP, IPV, DTaP-IPV, Hib, DTaP-IPV/Hib, DTaP-IPV/Hib-HepB, Td, Tdap, MMR, Japanese encephalitis (inactivated vaccine and live vaccine), chicken pox, hepatitis A (pediatric), rotavirus 1-valent and 5-valent
Strengthening the supply and distribution of vaccines for national preventive vaccination program
- (Supply Monitoring) Monitoring vaccine supply outlook for the next year by comparing production and import plans of vaccine manufacturers and importers with expected vaccine demand
- When instability of the supply is expected, timely responses will be achieved through consultations among related agencies.
- (Strengthening Distribution) Mandatory submission of distribution business plans and on-site inspections to check the proper storage and cold chain management of vaccines for contracted procurement companies
Addressing instability in the supply of vaccines for national preventive vaccination program and preparing for future pandemics
- (Vaccine Stockpiling) Continuously promoting the operation and expansion of stockpiled vaccines to prepare for instability in the vaccine supply * (As of July 2025) 4 types of stockpiled vaccines for national preventive vaccination program: intradermal BCG (tuberculosis), MMR (measles, mumps, and rubella), PPSV (pneumococcal), and Tdap (diphtheria, tetanus, and pertussis).
- (Establishing a Rapid Introduction System) Preparedness for the rapid introduction of vaccines in response to the emergence of new infectious diseases, including the establishment of relevant operational regulations